Prediction of nucleating sequences from amyloidogenic propensities of tau-related peptides

Biochemistry

Volumn 45, Issue 14, 2006, Pages 4638-4652

  Rojas Quijano, Federico A ^a   Morrow, Dana ^a   Wise, Barry M ^c   Brancia, Francesco L ^b   Goux, Warren J ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b Shimadzu Research Laboratory   (United Kingdom)

^c EIGENVECTOR RESEARCH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOMERS; NITROGEN COMPOUNDS; NUCLEATION; PRINCIPAL COMPONENT ANALYSIS; TRANSMISSION ELECTRON MICROSCOPY;

AGGREGATION KINETICS; AMYLOID-FORMING; HELICAL FILAMENT STRUCTURE; POLYMERIZATION RATE;

AMINO ACIDS;

ACETYLVALYLGLUTAMYLISOLEUCYLVALYLCYSTEINYLLYSINAMIDE; ACETYLVALYLGLUTAMYLISOLEUCYLVALYLTYROSYLLYSINAMIDE; AMINO ACID; AMYLOID; CONGO RED; ISOLEUCYLVALYLTYROSYLLYSINE; MONOMER; TAU PROTEIN; UNCLASSIFIED DRUG; VALYLALANYLVALYLVALYLARGININE; VALYLGLUTAMYLISOLEUCYLISOLEUCYLASPARAGINYLLYSINE; VALYLGLUTAMYLISOLEUCYLVALYLTYROSYLLYSINE;

ARTICLE; CIRCULAR DICHROISM; ENERGY; HYDROPHOBICITY; INFRARED SPECTROSCOPY; MICROTUBULE; MOLECULAR STABILITY; PAIRED HELICAL FILAMENT; PARTITION COEFFICIENT; POLYMERIZATION; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN STRUCTURE; SOLUBILITY; STRUCTURE ACTIVITY RELATION; TRANSMISSION ELECTRON MICROSCOPY;

AMINO ACID SUBSTITUTION; AMYLOID; CIRCULAR DICHROISM; CONGO RED; HUMANS; HYDROPHOBICITY; MICROSCOPY, ELECTRON, TRANSMISSION; OLIGOPEPTIDES; PRINCIPAL COMPONENT ANALYSIS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SPECTROPHOTOMETRY, INFRARED; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TAU PROTEINS; THERMODYNAMICS;

EID: 33645669165     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi052226q     Document Type: Article

References (116)

1. McParland, V. J., Kalverda, A. P., Homans, S. W., and Radford, S. E. (2002) Structural properties of an amyloid precursor of beta-(2)-microglobulin, Nat. Struct. Biol. 9, 326-331.
2. Lansbury, P. T. (1992) In pursuit of the molecular structure of amyloid plaque: New technology provides unexpected and critical information, Biochemistry 31, 6865-6870.
3. Azriel, R., and Gazit, E. (2001) Analysis of the minimal amyloid-forming fragment of the islet amyloid polypeptide, J. Biol. Chem. 276, 34156-34161.
4. Lansbury, P. T. (1996) A reductionist view of Alzheimer's disease, Acc. Chem. Res. 29, 317-321.
5. Kelly, J. W. (1996) Alternative conformations of amyloidogenic proteins govern their behavior, Curr. Opin. Struct. Biol. 6, 11-17.
6. Prusiner, S. B. (1997) Prion diseases and the BSE crisis, Science 278, 245-250.
7. Kelly, J. W. (1997) Amyloid fibril formation and protein misassembly: a structural quest for insights into amyloid and prion diseases, Structure 5, 595-600.
8. Kirschner, D. A., and Inouye, H. (2005) Alzheimer's β-amyloid: Insights into fibril formation and structure from Congo red binding, in Subcellular Biochemistry (Harris, R., and Fahrenholz, F., Eds.), Vol. 38, pp 203-224, Kluwer Academic/Plenum, New York.
9. Sipe, J. D., and Cohen, A. S. (2000) Review: history of the amyloid fibril, J. Struct. Biol. 130, 88-98.
10. Krebs, M. R. H., Bromley, E. H. C., and Donald, A. M. (2005) The binding of thioflavin-T to amyloid fibrils: localization and implications, J. Struct. Biol. 149, 30-37.
11. Sunde, M., and Blake, C. C. F. (1997) The structure of amyloid fibrils by electron microscopy and X-ray diffraction, Adv. Protein Chem. 50, 123-159.
12. LeVine, H., III (1993) Thioflavine T interaction with synthetic Alzheimer's disease β-amyloid peptides: detection of amyloid aggregation in solution, Protein Sci. 2, 404-410.
13. Zurdo, J., Guijarro, J. I., Jimenez, J. L., Saibil, H. R., and Dobson, C. M. (2001) Dependence on solution conditions of aggregation and amyloid formation by an SH3 domain, J. Mol. Biol. 311, 325-340.
14. MacPhee, C. E. and Dobson, C. M. (2000) Chemical dissection and reassembly of amyloid fibrils formed by a peptide fragment of transthyretin, J. Mol. Biol. 297, 1203-1215.
15. Goux, W. J. (2002) The conformations of filamentous and soluble tau associated with Alzheimer paired helical filaments, Biochemistry 41, 13798-13806.
16. Goux, W. J., Kopplin, L., Nguyen, A. D., Leak, K., Rutkofsky, M., Shanmuganandam, V. D., Sharma, D., Inouye, H., and Kirschner, D. A. (2004) The formation of straight and twisted filaments from short tau peptides, J. Biol. Chem. 279, 26868-26875.
17. Kad, N. M., Myers, S. L., Smith, D. P., Smith, D. A., Radford, S. E., and Thomson, N. H. (2003) Hierarchical assembly of β2-microglobulin amyloid in vitro revealed by atomic force microscopy, J. Mol. Biol. 330, 785-797.
18. β40 in vitro accumulate protofibrils, including amyloid pores, J. Mol. Biol. 332, 795-808.
19. Hoshi, M., Sato, M., Matsumoto, S., Noguchi, A., Yasutake, K., Yoshida, N. and Sato, K. (2003) Spherical aggregates of β-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3β, Proc. Natl. Acad. Sci. U.S.A. 100, 6370-6375.
20. Ishimaru, D., Andrade, L. R., Teixeira, L. S. P., Quesado, P. A., Maiolino, L. M., Lopez, P. M., Cordeiro, Y., Costa, L. T., Heckl, W. M., Weissmuller, G., Foguel, D., and Silva, J. L. (2003) Fibrillar aggregates of the tumor suppressor p53 core domain, Biochemistry 42, 9022-9027.
21. Rochet, J. C., Lansbury, P. T., Jr. (2000) Amyloid fibrillogenesis: themes and variations, Curr. Opin. Struct. Biol. 10, 60-68.
22. Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., Taddei, N., Ramponi, G., Dobson, C. M., and Stefani, M. (2002) Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases, Nature 416, 507-511.
23. Quist, A., Doudevski, I., Lin, H., Azimova, R., Ng, D., Frangione, B., Kagan, B., Ghiso, J., and Lal, R. (2005) Amyloid ion channels: a common structural link for protein-misfolding disease, Proc. Natl. Acad. Sci. U.S.A. 102, 10427-10432.
24. Guijarro, J. I., Sunde, M., Jones, J. A., Campbell, I. D. and Dobson, C. M. (1998) Amyloid fibril formation by an SH3 domain, Proc. Natl. Acad. Sci. U.S.A. 95, 4224-4228.
25. Booth, D. R., Sunde, M., Bellotti, V., Robinson, C. V., Hutchinson, W. L., Fraser, P. E., Hawkins, P. N., Dobson, C. M., Radford, S. E., Blake, C. C. R., and Pepys, M. B. (1997) Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis, Nature 385, 787-793.
26. Chiti, F., Taddei, N., Baroni, F., Capanni, C., Stefani, M., Ramponi, G., and Dobson, C. M. (2002) Kinetic partitioning of protein folding and aggregation, Nat. Struct. Biol. 9, 137-143.
27. Liu, R., McAllister, C., Lyubchenko, Y., and Sierks, M. R. (2004) Residues 17-20 and 30-35 of beta-amyloid play critical roles in aggregation, J. Neurosci. Res. 75, 162-171.
28. Ramirez-Alvarado, M., Merkel, J. S., and Regan, L. (2000) A systematic exploration of the influence of the protein stability on amyloid formation in vitro, Proc. Natl. Acad. Sci. U.S.A. 97, 8979-8984.
29. Smith, D. P., Jones, S., Serpell, L. C., Sunde, M., and Radford, S. E. (2003) A systematic investigation into the effect of protein destabilization on beta 2-microglobulin amyloid formation, J. Mol. Biol. 330, 943-954
30. Dobson, C. M. (1999) Protein misfolding, evolution and disease, Trends Biochem. Sci. 24, 329-332.
31. Nilsson, M. R., and Dobson, C. M. (2003) In vitro characterization of lactoferrin aggregation and amyloid formation, Biochemistry 42, 375-382.
32. Cottingham, M. G., Hollinshead, M. S., and Vaux, D. J. T. (2002) Amyloid fibril formation by a synthetic peptide from a region of human acetylcholinesterase that is homologous to the Alzheimer's amyloid-β peptide, Biochemistry 41, 13539-13547.
33. Pawar, A. P., DuBay, K. F., Zurdo, J., Chiti, F., Vendruscolo, M., and Dobson, C. M. (2005) Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases, J. Mol. Biol. 350, 379-392.
34. DuBay, K. F., Pawar, A. P., Chiti, F., Zurdo, J., Dobson, C. M., and Vendruscolo, M. (2004) Prediction of the absolute aggregation rates of amyloidogenic polypeptide chains, J. Mol. Biol. 341, 1317-1326.
35. 311) forming β structure. Proc. Natl. Acad. Sci. U.S.A. 97, 5129-5134.
36. Gamblin, T. C. (2005) Potential structure/function relationships of predicted secondary structural elements of tau, Biochim. Biophys. Acta 1739, 140-149.
37. Reches, M., Porat, Y., and Gazit, E. (2002) Amyloid fibril formation by pentapeptide and tetrapeptide fragments of human calcitonin, J. Biol. Chem. 277, 35475-35480.
38. Mazor, Y., Gilead, S., Benhar, I., and Gazit, E. (2002) Identification and characterization of a novel molecular-recognition and self-assembly domain within the islet amyloid polypeptide, J. Mol. Biol. 322, 1013-1024.
39. Cherney, I., Rockah, L., Levy-Nissenbaum, O., Gophna, U., Ron, E. Z., Gazit, E. (2005) The formation of Escherichia coli curli amyloid fibrils is mediated by prion-like peptide repeats, J. Mol. Biol. 352, 245-252.
40. Tjernberg, L., Hosia, W., Bark, N., Thyberg, J., and Johansson, J. (2002) Charge attraction and β propensity are necessary for amyloid fibril formation from tetrapeptide, J. Biol. Chem. 277, 43243-43246.
41. Porat, Y., Mazor, Y., Efrat, S., Gazit, E. (2004) Inhibition of islet amyloid polypeptide fibril formation: a potential role for heteroaromatic interactions, Biochemistry 43, 14454-14462.
42. Scrocchi, L. A., Ha, K., Chen, Y., Wu, L., Wang, F., and Fraser, P. E. (2003) Identification of minimal peptide sequences in the (8-20) domain of human islet amyloid polypeptide involved in fibrillogenesis, J. Struct. Biol. 141, 218-227.
43. Ventura, S., Zurdo, J. Narayanan, S., Parreno, M., Mangues, R., Reif, B., Chiti, F., Giannoni, E., Dobson, C. M., Aviles, F. X., and Serrano, L. (2004) Short amino acid stretches can mediate amyloid formation in globular proteins: The Src homology 3 (SH3) case, Proc. Natl. Acad. Sci. U.S.A. 101, 7258-7263.
44. Vauthey, S., Santoso, S., Gong, H., Watson, N., and Zhang, S. (2002) Molecular self-assembly of surfactant-like peptides to form nanotubes and nanovesicles, Proc. Natl. Acad. Sci. U.S.A. 99, 5355-5360.
45. Caplan, M. R., Moore, P. N., Zhang, S., Kamm, R. D., and Lauffenburger, D. A. (2000) Self-assembly of a β-sheet protein governed by relief of electrostatic repulsion relative to van der Waals attraction, Biomacromolecules 1, 627-631.
46. Kammerer, R. A., Kostrewa, D., Zurdo, J., Detken, A., Garcia-Echeverria, C., Green, J. D., Muller, S. A., Meier, B. H., Winkler, F. K., Dobson, C. M., and Steinmetz, M. O. (2004) Exploring amyloid formation by a de novo design, Proc. Natl. Acad. Sci. U.S.A. 101, 4435-4440.
47. West, M. W., Wang, W., Patterson, J., Mancias, J. D., Beasley, J. R., and Hect, M. H. (1999) De novo amyloid proteins from designed combinatorial libraries, Proc. Natl. Acad. Sci. U.S.A. 96, 11211-11216.
48. Zhang, S., and Rich, A. (1997) Direct conversion of an oligopeptide from a beta-sheet to an alpha-helix: a model for-amyloid formation, Proc. Natl. Acad. Sci. U.S.A. 94, 23-28.
49. Blondelle, S. E., Forood, B., Houghten, R. A., and Perez-Paya, E. (1997) Polyalanine-based peptides as models for self-associated β-pleated-sheet, Biochemistry 36, 8393-8400.
50. Soreghan, B., Kosmoski, J., and Glabe, C. (1994) Surfactant properties of Alzheimer's A beta peptides and the mechanism of amyloid aggregation, J. Biol. Chem. 269, 28551-28554.
51. Lopez de la Paz, M., Lacroix, E., Ramirez-Alverado, M., and Serrano, L. (2001) Computer-aided design of β-sheet peptides, J. Mol. Biol. 312, 229-246.
52. Lopez de la Paz, M., Goldie, K., Zurdo, J., Lacroix, E., Dobson, C. M., Hoenger, A., and Serrano, L. (2002) De novo designed peptide-based amyloid fibrils, Proc. Natl. Acad. Sci. U.S.A. 99, 16052-16057.
53. Lopez de la Paz, M., and Serrano, L. (2004) Sequence determinants of amyloid fibril formation, Proc. Natl. Acad. Sci. U.S.A. 101, 87-92.
54. Pastor, M. T., Lopez de la Paz, M., Lacroix, E., Serrano, L., and Perez-Paya, E. (2002) Combinatorial approaches: A new tool to search for highly structured β-hairpin peptides, Proc. Natl. Acad. Sci. U.S.A. 99, 614-619.
55. Kosik, K. S., and Greenberg, S. M. (1994) Tau proteins and Alzheimer disease, in Alzheimer Disease (Terry, R. D., Katzman, R., and Bick, K. L., Eds.), pp 335-344, Raven Press, New York.
56. von Bergen, M., Sarghorn, S., Biernat, J., Mandelkow, E. M., Mandelkow, E. (2005) Tau aggregation is driven by a transition from random coil to β-sheet structure, Biochim. Biophys. Acta 7739, 158-166.
57. Mandelkow, E. M., Schweers, O., Drewes, G., Biernat, J., Gustke, N., Trinczek, B., and Mandelkow, E. (1996) Structure, microtubule interactions, and phosphorylation of tau protein, Ann. N.Y. Acad. Sci. 777, 96-106.
58. Friedhoff, P., von Bergen, M., Mandelkow, E. M., and Mandelkow E. (2000) Structure of tau protein and assembly into paired helical filaments, Biochim. Biophys. Acta 1502, 122-132.
59. Mandelkow, E. M., Mandelkow, E. (1998) Tau in Alzheimer's disease, Trends Cell Biol. 8, 425-427.
60. Feany, M. B., and Dickson, D. W. (1996) Neurodegenerative disorders with extensive tau pathology: A comparative study and review, Ann. Neurol. 40, 139-148.
61. Dickson, D. W., Crystal, H. A., Bevona, C., Honer, W., Vincent, I., and Davies, P. (1995) Correlations of synaptic and pathological markers with cognition of the elderly, Neurobiol. Aging 16, 285-298.
62. von Bergen, M., Barghorn, S., Li, L., Marx, A., Biernat, J., Mandelkow, E.-M., and Mandelkow, E. (2001) Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local β-structure, J. Biol. Chem. 276, 48165-48174.
63. Kirschner, D. A., Abraham, C., and Selkoe, D. J. (1986) X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-β conformation, Proc. Natl. Acad. Sci. U.S.A. 83, 503-507.
64. Berriman, J., Serpell, L. C., Oberg, K. A., Fink, A. L., Goedert, M., and Crowther, R. A. (2003) Tau filaments from human brain and from in vitro assembly of recombinant protein show cross-beta structure, Proc. Natl. Acad. Sci. U.S.A. 100, 9034-9038.
65. Abraha, A., Ghoshal, N., Gamblin, T. C., Cryns, V., Berry, R. W., Kuret, J., and Binder, L. I. (2000) C-terminal inhibition of tau assembly in vitro and in Alzheimer's disease, J. Cell Sci. 113, 3737-3745.
66. Jonsson, J., Eriksson, L., Hellberg, S., Sjöström, M., and Wold, S. (1989) Multivariate parametrization of 55 coded and noncoded amino acids, Quant. Struct.-Act. Relat. 8, 204-209.
67. Hellberg, S., Sjöström, M., Skagerberg, B., and Wold, S. (1986) Peptide quantitative structure-activity relationships, a multivariate approach, J. Med. Chem. 30, 1126-1135.
68. Sandberg, M., Eriksson, L., Jonsson, J., Sjöström, M., and Wold, S. (1998) New chemical descriptors relevant for the design of biologically active peptides. A multivariate characterization of 87 amino acids, J. Med. Chem. 41, 2481-2491.
69. Wold, S., Sjöström, M., and Eriksson, L. (2001) PLS-regression: a basic tool of chemometrics, Chemom. Intell. Lab. Syst. 58, 109-130.
70. Choma, C. T., Lear, J. D., Nelson, M. J., Dutton, P. L., Robertson, D. E., and DeGrado, W. F. (1994) Design of a heme-binding four-helix bundle, J. Am. Chem. Soc. 116, 856-865.
71. Ostresh, J. M., Winkle, J. H., Hamashin, V. T., Houghten, R. A. (1994) Peptide libraries: determination of relative reaction rates of protected amino acids in competitive couplings, Biopolymers 34, 1681-1689.
72. Haris, P. I., Chapman, D. (1995) The conformational-analysis of peptides using Fourier transform IR spectroscopy, Biopolymers 37, 251-263.
73. Bandekar, J. (1992) Amide modes and protein conformation, Biochim. Biophys. Acta 1120, 123-143.
74. 2O) solutions. 2. Amide absorption-bands of polypeptides and fibrous proteins in alpha-coil, beta-coil, and random coil conformations, Biopolymers 30, 1259-1271.
75. Zurdo, J., Guijarro, J. I., and Dobson, C. M. (2001) Preparation and characterization of purified amyloid fibrils, J. Am. Chem. Soc. 123, 8141-8142.
76. Edelhock, H. (1967) Spectroscopic determination of tryptophan and tyrosine in proteins, Biochemistry 6, 1948-1954.
77. Gill, S. C., and von Hippel, P. H. (1989) Calculation of protein extinction coefficients from amino acid sequence data, Anal. Biochem. 182, 319-326.
78. Khurana, R., Uversky, V. N., Nielsen, L., and Fink, A. L. (2001) Is Congo red an amyloid-specific dye? J. Biol. Chem. 276, 22715-22721.
79. Klunk, W. E., Jacob, R. F., and Mason, R. P. (1999) Quantifying amyloid β-peptide (Aβ) aggregation using the Congo red-Aβ (CR-Aβ) spectroscopic assay, Anal. Biochem. 266, 66-76.
80. Friedhoff, P., Schneider, A., Mandelkow, E. M., and Mandelkow, E. (1998) Rapid assembly of Alzheimer-like paired helical filaments from microtubule-associated protein tau monitored by fluorescence in solution, Biochemistry 37, 10223-10230.
81. Friedhoff, P., von Bergen, M., Mandelkow, E. M., and Mandelkow, E. (1998) A nucleated assembly mechanism of Alzheimer paired helical filaments, Proc. Natl. Acad. Sci. U.S.A. 95, 15712-15717.
82. LeVine, H., III (1999) Quantification of beta-sheet amyloid fibril structures with thioflavin T, Methods Enzymol. 309, 274-284.
83. Necula, M., and Kuret, J. (2004) Pseudophosphorylation and glycation of tau protein enhance but do not trigger fibrillization in vitro, J. Biol. Chem. 279, 49694-49703.
84. Pace, C. N., Shirley, B. A., and Thomson, J. A. (1989) in Protein Structure: A Practical Approach (Creighton, T. E., Ed.), pp 311-330, Oxford Press, New York.
85. 13C nuclear magnetic resonance spectroscopy, J. Mol. Biol. 145, 583-602.
86. Brancia, F. L., Montgomery, H., Tanaka, K., and Kumashiro, S. (2004) Guanidino labeling derivatization strategy for global characterization of peptide mixtures by liquid chromatography matrix-assisted laser desorption/ionization mass spectrometry, Anal. Chem. 76, 2748-2755.
87. Sharaf, M. A., Illman, D. L., and Kowalski, B. R. (1986) Chemometrics, in Chemical Analysis: A series of monographs on Analtyical Chemistry and its Applications, (Elving, P. J., Winefordner, J. D., Kolthoff, I. M., Eds.), Vol. 82, pp 179-295, John Wiley & Sons, New York.
88. Sreerama, N., Venyaminov, S. Y., and Woody, R. W. (2000) Estimation of protein secondary structure from circular dichroism spectra: inclusion of denatured proteins with native proteins in the analysis, Anal. Biochem. 287, 243-251.
89. Sreerama, N., Venyaminov, S. Y., and Woody, R. W. (2001) Analysis of protein circular dichroism spectra based on the tertiary structure classification, Anal. Biochem. 299, 271-274.
90. Woody, R. W. (1978) Aromatic side-chain contributions to the far ultraviolet circular dichroism of peptides and proteins, Biopolymers 17, 1451-1467.
91. Goux, W. J., and Hooker, T. M., Jr. (1980) Chiroptical properties of proteins. 1. Near-ultraviolet circular dichroism of ribonuclease S, J. Am. Chem. Soc. 102, 7080-7087.
92. Hirota-Nakaoka, N., Hasegawa, K., Naiki, H., and Goto, Y. (2003) Dissolution of beta2-microglobulin amyloid fibrils by dimethylsulfoxide, J. Biochem. (Tokyo) 134, 159-164.
93. Higham, C. E., Jaikaran, E. T., Fraser, P. E., Gross, M., and Clark, A. (2000) Preparation of synthetic human islet amyloid polypeptide (IAPP) in a stable conformation to enable study of conversion to amyloid-like fibrils, FEBS Lett. 17, 55-60.
94. Kayed, R., Bernhagen, J., Greenfield, N., Sweimeh, K., Brunner, H., Voelter, W., and Sapurniotu, A. (1999) Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro, J. Mol. Biol. 287, 781-796.
95. Mathis, C. A., Wang, Y. M., Holt, D. P., Huang, G. F., Debnath, M. L., and Klunk, W. E. (2003) The synthesis and evaluation of C-11-labeled-6- substituted 2-arylbenzothiazoles as amyloid imaging agents, J. Med. Chem. 46, 2740-2754.
96. Chou, P. Y., and Fasman, G. D. (1978) Prediction of the secondary structure of proteins from their amino acid sequence, Adv. Enzymol. Relat. Areas Mol. Biol. 47, 45-148.
97. Kim, C. A., and Berg, J. M. (1993) Thermodynamic β-sheet propensities measured using a zinc-finger host peptide, Nature 362, 267-270.
98. Petkova, A. T., Leapman, R. D., Guo, Z., Yau, W. M., Mattson, M. P., and Tycko, R. (2005) Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils, Science 307, 262-265.
99. Wood, S. J., Setzel, Martin, J. D., and Hurle, M. R. (1995) Prolines and amyloidogenicity in fragments of the Alzheimer's peptide β/A4, Biochemistry 34, 724-730.
100. Barghorn, S., Zheng-Fischhofer, Q., Ackmann, M., Biernat, J., von Bergen, M., Mandelkow, E. M., and Mandelkow, E. (2000) Structure, microtubule interactions, and paired helical filament aggregation by tau mutants of frontotemporal dementias, Biochemistry 39, 11714-11721.
101. Tartaglia, G. G., Cavalli, A., Riccardo, P., and Caflisch, A. (2004) The role of aromaticity, exposed surface, and dipole moment in determining protein aggregation rates, Protein Sci. 13, 1939-1941.
102. Goedert., M., Wischik, C. M., Crowther, R. A., Walker, J. E., and Klug, A. (1988) Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: Identification as the microtubule-associated protein tau, Proc. Natl. Acad. Sci. U.S.A. 85, 4051-4055.
103. Wischik, C. M., Novak, M., Thøgersen, H. C., Edwards, P. C., Runswick, M. J., Jakes, R., Walker, J. E., Milstein, C., Roth, M., and Klug, A. (1988) Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease, Proc. Natl. Acad. Sci. U.S.A. 85, 4506-4510.
104. Wischik, C. M., Novak, M., Edwards, P. C., Klug, A., Tichelaar, W., and Crowther, R. A. (1988) Structural characterization of the core of the paired helical filament of Alzheimer disease, Proc. Natl. Acad. Sci. U.S.A. 85, 4884-4888.
105. Jakes, R., Novak, M., Davison, M., and Wischik, C. M. (1991) Identification of 3- and 4-repeat tau isoforms within the PHF in Alzheimer's disease, EMBO J. 10, 2725-2729.
106. Wille, H. Drewes, G., Biernat, J., Mandelkow, E. M., Mandelkow, E. (1992) Alzheimer-like paired helical filaments and antiparallel dimmers formed from microtubule-associated protein tau in vitro, J. Cell Biol. 118, 573-584.
107. Mukrasch, M. D., Biernat, J., von Bergen, M., Griesinger, C., Mandelkow, E., and Zweckstetter, M. (2005) Sites of tau important for aggregation populate β-structure and bind to microtubules and polyanions, J. Biol. Chem. 280, 24978-24986.
108. Sillen, A., Leroy, A., Wieruszeski, J. M., Loyens, A., Beauvillain, J. C., Buée, L., Landrieu, I., and Lippens, G. (2005) Regions of tau implicated in the paired helical fragment core as defined by NMR, ChemBioChem 6, 1849-1856.
109. Yanagawa, H., Chung, S.-H., Ogawa, Y., Sato, K., Shibata-Seki, T., Masai, J., and Ishiguro, K. (1998) Protein Anatomy: C-tail region of human tau protein as a crucial structural element in Alzheimer's paired helical filament formation in vitro, Biochemistry 37, 1979-1988.
110. Ghoshal, N., Garcia-Sierra, F., Wuu, J., Leurgans, S., Bennett, D. A., Berry, R. W., and Binder, L. I. (2002) Tau conformational changes correspond to impairments of episodic memory in mild cognitive impairment and Alzheimer's disease, Exp. Neurol. 177, 475-493.
111. Jicha, G. A., Bowser, R., Kazam, I. G., and Davies, P. (1997) Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau, J. Neurosci. Res. 48, 128-132.
112. Jicha, G. A., Berenfeld, B., and Davies, P. (1999) Sequence requirements for formation of conformational variants of tau similar to those found in Alzheimer's disease, J. Neurosci. Res. 55, 713-723.
113. Li, L., von Bergen, M., Mandelkow, E. M., and Mandelkow, E. (2002) Sutructure, stability, and aggregation of paired helical filaments from tau protein and FTDP-17 mutants probed by tryptophan scanning mutagenesis, J. Biol. Chem. 277, 41390-41400.
114. Gamblin, T. C., Berry, R. W., and Binder, L. I. (2003) Tau polymerization: Role of the amino terminus, Biochemistry 42, 2252-2257.
115. King, M. E., Gamblin, T. C., Kuret, J., and Binder, L. I. (2000) Differential assembly of human tau isoforms in the presence of arachidonic acid, J. Neurochem. 74, 1749-1757.
116. Goedert, M., Ghetti, B., and Spillantini, M. G. (2000) Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Their relevance for understanding the neurodegenerative process, Ann. N.Y. Acad. Sci. 920, 74-83.